Harbour BioMed and Glenmark Pharmaceuticals Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers

Life Science

Nanjing Sanpower Transfers Dendreon to Cenbest for $868 Million

Life Science

Shandong Luoxin Acquires Constipation Drug in $68 Million Agreement

Life Science

Google Glass may help kids with autism read facial expressions

Life Science, Technology

Denali Shares Pop After Positive Parkinson’s Trial Data

Life Science

Impact Therapeutics Closes $30 Million C Round for Cancer Drugs

Life Science

Life Science & Technology Weekly 154 – Manulife launches Canada’s first medical marijuana program with Shoppers Drug Mart

Cannabis, Life Science

BeiGene Sets Price for Honk Kong IPO, Rakes in Almost $1 Billion

Life Science

Chinese, US Scientists Develop Skin Patch Nanoparticle Flu Vaccine

Life Science

CY Biotech Acquires China Rights to Obesity Treatment from Eisai

Life Science

Hydropothecary, Molson banking on Canadians’ thirst for cannabis-infused drinks

Cannabis, Life Science

Clover Biopharmaceuticals Initiates Phase I Study of Etanercept Biosimilar Candidate SCB-808 in China

Life Science

China’s Ascletis Debuted: Stocks Flat

Life Science

CMS in $70 Million Deal for French Thrombotic Therapy

Life Science

China Diagnostics Medical Raises $292 Million led by Legend’s $100 Million

Life Science